Cannabics Pharmaceuticals opens up new lab and prepares to accept fresh biopsies
Cannabics Pharmaceuticals Inc (OTCQB:CNBX) CEO Eyal Barad joined Proactive Investors' Steve Darling at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. The biotechnology company develops pharmaceuticals focusing on cancer research and focuses on the development of therapies and tools aimed at diverse ailments.
Quick facts: Cannabics Pharmaceuticals
Market Cap: $34.96 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE